RecruitingNot ApplicableNCT07501923

The Effects of Daytime, Nighttime, and Combined Heat Exposure on Human Health

Randomized Controlled Crossover Trial on the Effects of Daytime, Nighttime, and Combined Heat Exposure on Human Health


Sponsor

Jian Cheng

Enrollment

35 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Assess the acute effects of high-temperature exposure (including both daytime and nighttime conditions) on multiple physiological and psychological indicators, including cardiovascular, respiratory, neuropsychiatric, and metabolic functions, along with their potential mechanisms.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Daytime and nighttime neutral temperature exposure and Daytime or Nighttime High-Temperature Exposure for people with cardiovascular system, metabolism changes, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDaytime or Nighttime High-Temperature Exposure

Daytime Exposure Phase: The exposure group will be exposed to high temperature (32#) in a chamber for about 8 hours, resting during the whole periods Nighttime Exposure Phase: The exposure group will be exposed to high temperature (30#) in a chamber for about 8 hours, resting during the whole periods Day-Night Combined Exposure Phase: The exposure group will be exposed continuously to high temperatures during the day and night

OTHERDaytime and nighttime neutral temperature exposure

Daytime Exposure Phase: The control group will be exposed to neutraltemperature (26#) in a chamber for about 8 hours, resting during the whole periods Nighttime Exposure Phase: The control group will be exposed to neutral temperature (26#) in a chamber for about 8 hours, resting during the whole periods Day-Night Combined Exposure Phase: The control group will be exposed continuously to neutraltemperatures during the day and night


Locations(1)

Anhui Medical University

Hefei, Anhui, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07501923


Related Trials